Health2Tech Philly June 10, 2026
Date June 10
Time 5:30 PM - 8:30 PM
Location Philadelphia
Past event

Philadelphia, June 10, 2026

This event took place on June 10, 2026.

Join us on June 10th for an exclusive gathering that brings together the brightest minds in the digital health space. Hosted by Alex Koshykov and Linda Alunkal, this evening promises to be a confluence of innovation, inspiration, and invaluable networking.

Schedule

How the event runs

5:30 pm - 6:00 pm
Doors Open
6:00 pm - 7:00 pm
"Where Innovation Fails: Why Adoption, Not Capital, Determines Outcomes in Healthcare AI" by Mohammed Quadri.
7:00 pm - 8:30 pm
Networking
Speakers

Who is on stage

Dr. Mohammed Quadri, MD, MBA

Dr. Mohammed Quadri, MD, MBA

Founder & Managing Partner, GrowQ360

Theme Where Innovation Fails: Why Adoption, Not Capital, Determines Outcomes in Healthcare AI

Dr. Mohammed Quadri is a physician, investor, and Founder of GrowQ360, a venture-to-adoption platform focused on healthcare AI and digital health. His work sits at the intersection of clinical care, capital, and real-world deployment, with a focus on accelerating adoption within health systems. He works closely with clinicians, operators, and innovators to bridge the gap between innovation and scalable implementation, particularly in high-friction areas such as patient access, clinical workflows, and revenue cycle optimization.

Powering the community

Sponsors and Partners

​Tactix

​In 1997, Tactix set out to radically change the commercial real estate brokerage model. We believed by hiring the smartest and most experienced brokers, creating a culture of collaboration and teamwork, encouraging teams to form around the client’s specific needs, and committing to never (ever) represent landlords, we could change brokerage as usual. Almost 30 years later, we are still fulfilling that mission every day.

J.P. Morgan serves venture-backed and high-growth startups, founders, and venture capital firms across the globe. We provide deep industry expertise, local support, global products and services, and a robust network of investors and partners to meet your commercial, investment, and private banking needs.

​​Additionally, J.P. Morgan has a complimentary Cap Table solution that is complimentary for up to 40 stakeholders.  If you’ve been looking for an alternative way to manage your firm’s equity ownership and bring your reward strategy to life, please reach out.

Health2Tech Boston, May 12, 2025
Date May 12
Time 5:30 PM - 8:00 PM
Location Boston
Past event

Boston, May 12, 2026

This event took place on May 12, 2026.

Join us on May 12th for an exclusive gathering of top leaders and innovators in the health AI space. Hosted by Alex Koshykov & Amir Lahav, this evening offers a sneak peek at the highly anticipated DHAI summit coming to Boston this June. Expect the kind of unfiltered conversations, strategic insights, and high-level executive networking that rarely happen on public stages.

Schedule

How the event runs

5:30 pm - 6:00 pm
Doors Open & Arrivals Begin the evening with a warm welcome and initial networking with fellow industry leaders.
6:00 pm - 6:15 pm
Welcome remarks by Alex Koshykov and Amir Lahav
6:15 pm - 7:00 pm
An exclusive, early look at the main event. This rapid-fire panel features select DHAI 2026 speakers unpacking this year’s core theme: Augmenting Intelligence, Automating Operations, and Extending Life: The Future of Health AI.
7:00 pm - 8:00 am
Executive Networking Connect, converse, and collaborate with C-suite leaders, founders, and peers driven by a common passion for advancing healthcare through artificial intelligence.
Speakers

Who is on stage

​Michael Ringel

​Michael Ringel

COO, Life Bioscience

​Michael Ringel is Chief Operating Officer at Life Biosciences, a biotech company focused on partial epigenetic reprogramming to reverse age-related diseases. He is on the Boards of Hevolution Foundation US and the American Federation for Aging Research. Prior to working at Life Bio, Michael was Managing Director and Senior Partner at BCG, where he worked for 25+ years. Michael has a B.A. summa cum laude in biology from Princeton University, a Ph.D. in biology from Imperial College and a J.D. cum laude from Harvard Law School.

Mari Heghinian

Mari Heghinian

Founder, Seran LLC | VP of Science & Strategic Partnerships, SkyMedAI

Mari Heghinian, Founder, Seran LLC | VP of Science & Strategic Partnerships, SkyMedAI. She is experienced healthcare technology and clinical research leader specializing in clinical development/execution, AI-driven digital health, and strategy. Extensive experience in digital health innovation, clinical study design, and execution, with a proven ability to anticipate and mitigate risks while ensuring timely issue resolution and successful outcomes.

Erez Kaminski

Erez Kaminski

Founder & CEO, Ketryx

Erez Kaminski, CEO and Founder of Ketryx, brings over a decade of experience across the AI, biotech, and energy sectors. He specializes in developing mission-critical applications, ranging from pharmaceutical equipment monitoring to AI-driven medication management. Before founding Ketryx, Erez led AI and Machine Learning for Amgen’s medical device division. Having spent his career helping companies of all sizes build safer, more reliable products, Erez is now using Ketryx to improve patient outcomes and unlock new possibilities for regulated product development through AI.

Amir Lahav

Amir Lahav

Founder & CEO, SkyMedAI | Medical Director & Chair: The DHAI Summit

Amir Lahav is the Founder & CEO of SkyMedAI and a recognized Top Voice in Health AI. Drawing on a distinguished career at Harvard Medical School and Pfizer, Amir serves as a retained Strategic Advisor and Board Member for CXOs, investors, startups, and Pharma leaders. Leveraging battle-tested insights across neurological, rare, and chronic diseases, Amir is dedicated to helping companies turn AI vision into a commercial reality, identify clinical hazards before they become liabilities, and future-proof commercial assets in a rapidly evolving AI landscape. Beyond his advisory work, Amir is the Curator and Chair of the DHAI Summit and the author of The Sixth Algorithm™—an insightful and engaging newsletter exploring what it means to be human in an AI-driven world.

Powering the community

Sponsors and Partners

Ketryx transforms the product lifecycle of regulated teams to deliver safer products, faster. Trusted by four of the world’s top five medical device manufacturers, its AI-native compliance platform overlays existing tools to automate documentation, create traceability, and accelerate release cycles—without disrupting existing workflows. Ketryx AI Agents cut manual work by 90 percent and close compliance gaps, elevating speed and quality across the entire product lifecycle. For more information, visit www.ketryx.com.

​J.P. Morgan serves venture-backed and high-growth startups, founders, and venture capital firms across the globe. We provide deep industry expertise, local support, global products and services, and a robust network of investors and partners to meet your commercial, investment, and private banking needs.

​​​​Additionally, J.P. Morgan has a complimentary Cap Table solution that is complimentary for up to 40 stakeholders.  If you’ve been looking for an alternative way to manage your firm’s equity ownership and bring your reward strategy to life, please reach out.

 

Health2Tech NYC – May 14, 2026
Date May 14
Time 5:30 PM - 8:30 PM
Location New York
Past event

New York, May 14, 2026

This event took place on May 14, 2026.

Join us on May 14th for an exclusive gathering that brings together the brightest minds in the digital health space. Hosted by Bailey Morgan, this evening promises to be a confluence of innovation, inspiration, and invaluable networking.

Schedule

How the event runs

5:30 pm - 6:00 pm
Doors Open. Begin the evening with a warm welcome and a chance to settle in.
6:00 pm - 6:45 pm
Fire-side chat with Amir Lahav: "The future of health: How to stay competitive when everybody has AI"
6:45 pm - 8:30 pm
Networking
Speakers

Who is on stage

Amir Lahav

Amir Lahav

Founder & CEO of SkyMedAI

Amir Lahav is a founder of SkyMedAI. He is also a Clinical Scientist, Strategic Advisor, and Global Thought Leader at the forefront of Digital Health, Artificial Intelligence, and Modern Medicine. He is the curator and scientific director of the DHAI Summit. Amir sits on the advisory board of multiple medtech startups and holds strategic consulting roles with leading pharmaceutical companies. During his time at Pfizer, he led the development of wearable tech and remote monitoring solutions for gene therapy trials, primarily in rare diseases. Prior to pharma, he was a PI on numerous clinical trials as a Neurology Faculty and Professor of Pediatrics at Harvard Medical School.

Powering the community

Sponsors and Partners

​FINN Partners – more than an agency. Champions of change.

​​​FINN Partners is one of the fastest-growing global, independent marketing and communications agencies in the world, serving clients through a powerful combination of bold creativity, informed strategy, hands-on partnership, and highly specialized expertise.

​J.P. Morgan serves venture-backed and high-growth startups, founders, and venture capital firms across the globe. We provide deep industry expertise, local support, global products and services, and a robust network of investors and partners to meet your commercial, investment, and private banking needs.

​​​​Additionally, J.P. Morgan has a complimentary Cap Table solution that is complimentary for up to 40 stakeholders.  If you’ve been looking for an alternative way to manage your firm’s equity ownership and bring your reward strategy to life, please reach out.